Psychedelic-assisted therapy is one of the most promising developments in mental health care in decades. It is also one of the most documentation-intensive. AI tools built for standard talk therapy do not account for the unique phases, experiences, and confidentiality demands of PAT. Here is what practitioners need to know about where AI fits — and where most tools fall short.
The Documentation Challenge Unique to PAT
Most clinical documentation tools were designed for a straightforward model: a client arrives, you conduct a session, you write a note, and you repeat that cycle weekly until discharge. The tools assume a relatively uniform session structure. They assume the client is in an ordinary state of consciousness. They assume the treatment arc is linear.
Psychedelic-assisted therapy breaks every one of those assumptions.
PAT unfolds across at least three distinct phases, each with its own clinical demands and documentation requirements:
- Preparation. This phase involves thorough screening, medical history review, informed consent, psychoeducation about the substance and the process, intention setting, and the establishment of a strong therapeutic alliance. Documentation must capture readiness assessments, contraindication screening, and the client’s expectations and fears. For practitioners working within clinical trials, additional protocol-specific documentation is required.
- Dosing or ceremony. This is the phase most unlike anything in conventional therapy. The client may be in a non-ordinary state of consciousness for several hours. They may report visual imagery, somatic sensations, emotional catharsis, mystical-type experiences, or encounters with trauma material that surfaces in non-verbal or symbolic form. Standard progress note formats — SOAP, BIRP, DAP — were not designed to capture this kind of clinical material. Yet the dosing session is often the most clinically significant event in the entire treatment arc, and it must be documented accurately.
- Integration. Integration sessions help the client make meaning of their experience and translate insights into lasting change. Documentation here needs to track how material from the dosing session is being processed, what new themes are emerging, and how the client’s presenting concerns are shifting. Integration is not a single session — it can span weeks or months, and the documentation needs to reflect that continuity.
On top of this structural complexity, PAT practitioners face heightened confidentiality concerns. Many psychedelic substances remain legally restricted or sit in regulatory grey areas. Clients may be participating in clinical trials with strict data governance requirements. Others may be accessing therapy through state or jurisdictional exemptions, compassionate access schemes, or in contexts where the legal status of the substance is ambiguous. Documentation that is imprecise, insecure, or stored in systems without adequate protections creates risk for both the client and the practitioner.
The documentation burden that already weighs on therapists in conventional practice is significantly amplified in PAT. The volume is greater, the content is more complex, and the stakes around privacy are higher.
Why PAT Practitioners Need AI Documentation Support
The training pipeline for psychedelic-assisted therapy is accelerating. Programmes such as those offered by MAPS, Fluence, Naropa University, and various certificate providers are producing a growing cohort of clinicians who are trained in PAT modalities but may have limited experience with the specific documentation demands of this work. Training courses are often brief — ranging from weekend intensives to several-month programmes — and they understandably prioritise clinical skills over administrative workflow.
The result is that practitioners move quickly from training into practice, where the documentation demands are immediate and substantial. A single client episode in PAT can generate:
- An intake assessment and screening report
- Medical clearance documentation
- Informed consent specific to the substance and protocol
- Preparation session notes (often two to four sessions)
- A dosing session record
- Integration session notes (often four to eight sessions or more)
- Outcome measures and treatment reviews
- A discharge summary
Compare this to standard weekly psychotherapy, where the per-client documentation typically consists of an intake, a treatment plan, weekly progress notes, and a discharge summary. The PAT treatment arc generates significantly more documentation across more distinct document types, often compressed into a shorter overall timeframe.
This is precisely the kind of challenge that well-designed AI tooling can address — not by replacing clinical judgement, but by reducing the mechanical effort of producing structured, high-quality documentation at each phase of the treatment arc.
What AI-Assisted Documentation Looks Like for PAT
The first thing to understand is that generic AI tools — ChatGPT with a blank prompt, a general-purpose note-taking app, or a transcription service designed for business meetings — are not fit for purpose in PAT. They lack clinical framing, they do not understand the structure of psychedelic therapy, and they have no awareness of the documentation standards or regulatory context that practitioners operate within.
Purpose-built AI documentation support for PAT involves several key capabilities:
Pre-Built Clinical Prompt Templates
Rather than starting from a blank prompt every time, practitioners benefit from structured templates that are designed for each phase of the PAT arc. A preparation session template, for instance, would prompt for readiness indicators, contraindication screening outcomes, psychoeducation topics covered, alliance observations, and the client’s stated intentions. A dosing session template would prompt for timeline of the experience, substance and dosage, observed and reported phenomena, emotional and somatic responses, key themes or imagery, and practitioner observations about the client’s process. An integration template would prompt for material being processed, emerging insights, behavioural changes, and links back to presenting concerns and treatment goals.
The MycenAI Clinical Prompt Library provides exactly this — a downloadable collection of templates designed specifically for PAT documentation across the full treatment arc.
Orientation-Aware Prompting
PAT practitioners come from diverse clinical backgrounds and bring different theoretical orientations to the work. A practitioner trained in Internal Family Systems will frame a dosing session very differently from one working within a somatic experiencing framework, a transpersonal psychology lens, or a cognitive-behavioural integration model. AI documentation tools need to adapt to these orientations rather than imposing a single clinical language.
Orientation-aware prompting means that the same clinical material can be documented through the lens of IFS (tracking parts, exiles, protectors), somatic approaches (tracking body sensations, movement impulses, nervous system regulation), ACT (tracking psychological flexibility, values clarification, defusion), DBT (tracking distress tolerance, emotion regulation, interpersonal effectiveness), CBT (tracking cognitive distortions, behavioural activation, thought records), or psychodynamic and transpersonal frameworks (tracking unconscious material, archetypal imagery, spiritual emergence). The practitioner’s orientation shapes how the AI structures the output, ensuring the documentation reflects the clinician’s actual conceptualisation of the work.
Document Chaining Across the Treatment Arc
One of the most powerful applications of AI in PAT documentation is document chaining — a workflow where the output from one session becomes input context for the next. In PAT, this is not a convenience feature. It is a clinical necessity.
The preparation sessions establish intentions, identify fears, and surface relevant history. That material needs to be available when documenting the dosing session, so the practitioner can note where preparation themes appeared, how intentions were engaged, and what unexpected material emerged. The dosing session record then needs to feed forward into integration, so the clinician can track how specific experiences are being processed, revisited, or avoided across subsequent sessions.
Without document chaining, this continuity relies entirely on the practitioner’s memory and manual cross-referencing. With it, the AI can surface relevant context from earlier phases and help the clinician maintain a coherent narrative across the entire episode of care.
The Privacy Imperative
Privacy is a foundational concern in all clinical documentation. In PAT, it is elevated to an imperative. There are several reasons for this.
First, the legal landscape around psychedelic substances is uneven and evolving. In some jurisdictions, psilocybin therapy is legal or decriminalised. In others, possession of the substance remains a criminal offence regardless of the therapeutic context. Clients who participate in PAT — whether in clinical trials, state-approved programmes, or other legal frameworks — are disclosing their involvement with substances that carry legal risk. That disclosure must be protected with the highest available standard of security.
Second, the clinical material that surfaces in PAT is often extraordinarily sensitive. Dosing sessions can bring forward deeply buried trauma, experiences of abuse, existential crises, and profoundly personal spiritual or psychological content. Clients in these states are exceptionally vulnerable, and the documentation of their experiences must be handled with corresponding care.
Third, many PAT practitioners and their clients are, whether they recognise it or not, early participants in what will become a regulated industry. The documentation they create today may be subject to future regulatory scrutiny, and the security standards applied to that documentation will matter.
This is why software-only encryption is not sufficient. Standard cloud-based AI tools process data in server memory that is accessible to the platform operator, system administrators, and potentially to legal discovery. Even if data is encrypted at rest and in transit, it is decrypted during processing — and that is the point of vulnerability.
Hardware-secured processing — specifically, confidential computing using trusted execution environments (TEEs) — addresses this gap. TEEs encrypt data not just at rest and in transit, but during processing. The data is processed inside a hardware-isolated enclave that cannot be accessed by the cloud provider, the platform operator, or anyone other than the authenticated user. For a deeper exploration of how this technology evolved from physical record-keeping to modern hardware security, see From Filing Cabinets to Enclaves.
For PAT practitioners, this is not an abstract infrastructure decision. It is a direct clinical and ethical obligation. If you are asking clients to disclose their use of legally complex substances and to share the most vulnerable content of their inner lives, the tools you use to document that material must offer protections that match the sensitivity of the disclosure. Understanding how HIPAA intersects with AI processing is an essential part of this equation.
ConfideAI’s infrastructure is built on this principle. Every AI interaction is processed within a hardware-secured enclave, ensuring that clinical data — including the uniquely sensitive material generated in PAT — is never exposed to any party other than the practitioner.
Where This Is Heading
The psychedelic-assisted therapy field is at an inflection point. The U.S. FDA has granted breakthrough therapy designation to psilocybin for treatment-resistant depression and to MDMA-assisted therapy for PTSD. Australia’s TGA has approved the prescribing of psilocybin and MDMA by authorised psychiatrists. Regulatory frameworks are emerging in Canada, the United Kingdom, and across the European Union. State-level programmes in Oregon and Colorado are operationalising legal access to psilocybin outside of clinical trials.
As these frameworks mature, the documentation standards applied to PAT will tighten. Practitioners who are currently operating with improvised documentation workflows — adapting standard therapy note templates, writing free-form session summaries, or relying on memory to connect preparation, dosing, and integration records — will need to adopt more structured, auditable, and secure systems.
The tools need to match the maturity of the clinical work. PAT is no longer an experimental fringe. It is moving into mainstream clinical practice, and the documentation infrastructure must move with it. That means purpose-built templates that understand the phases of psychedelic therapy. It means orientation-aware AI that respects the diversity of clinical frameworks practitioners bring to this work. It means document chaining that maintains continuity across the full treatment arc. And it means privacy protections that are engineered at the hardware level, not bolted on as an afterthought.
The practitioners entering this field now are shaping how PAT will be documented, regulated, and understood for decades to come. The documentation choices they make today — what tools they use, what standards they adopt, how they protect client data — will establish the foundation for an entire clinical discipline.
Getting Started
MycenAI provides AI-assisted clinical documentation tools designed specifically for psychedelic-assisted therapy practitioners, built on ConfideAI’s hardware-secured infrastructure. The Clinical Prompt Library is available as a free download and includes structured templates for every phase of the PAT treatment arc — from intake screening through integration and discharge.
Visit confideai.ai to access the platform, or download the Clinical Prompt Library to start building a documentation workflow that matches the standard of care your clients deserve.